These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 32790917)

  • 1. Comparing incidences of infusion site reactions between brand-name and generic vinorelbine in patients with non-small cell lung cancer.
    Ozawa N; Hase T; Hatta T; Sagara A; Ichikawa K; Miyazaki M; Yogo N; Ando M; Hashimoto N; Yamada K; Hasegawa Y
    Br J Clin Pharmacol; 2021 Mar; 87(3):1318-1326. PubMed ID: 32790917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms.
    Gusella M; Pasini F; Caruso D; Barile C; Modena Y; Fraccon AP; Bertolaso L; Menon D; Crepaldi G; Bononi A; Spezzano R; Telatin GA; Corona G; Padrini R
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):493-500. PubMed ID: 30542768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II-IIIA non-small cell lung cancer: Propensity score-matched and instrumental variable analyses.
    Urushiyama H; Jo T; Yasunaga H; Michihata N; Matsui H; Hasegawa W; Takeshima H; Sakamoto Y; Hiraishi Y; Mitani A; Fushimi K; Nagase T; Yamauchi Y
    Cancer Med; 2018 Oct; 7(10):4863-4869. PubMed ID: 30151905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.
    Izumi H; Touge H; Igishi T; Makino H; Nishii-Ito S; Takata M; Nakazaki H; Ueda Y; Matsumoto S; Kodani M; Kurai J; Takeda K; Sakamoto T; Yanai M; Tanaka N; Nirodi CS; Shimizu E
    Int J Oncol; 2015 Mar; 46(3):989-98. PubMed ID: 25573239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
    Kanazawa J; Morimoto M; Ohmori K
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
    Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
    Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
    Martoni AA; Melotti B; Sperandi F; Giaquinta S; Piana E; Pavesi L; Da Prada G; Lelli G
    Lung Cancer; 2008 Jun; 60(3):387-92. PubMed ID: 18160123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of corticosteroids on phlebitis induced by intravenous infusion of antineoplastic agents in rabbits.
    Kohno E; Murase S; Matsuyama K; Okamura N
    Int J Med Sci; 2009 Aug; 6(5):218-23. PubMed ID: 19680474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
    Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
    Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Cancer Chemother Pharmacol; 1999; 44 Suppl():S1-4. PubMed ID: 10602901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: a phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Ann Oncol; 1998 May; 9(5):565-7. PubMed ID: 9653499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthracyclines in non-small-cell lung cancer: do they have a therapeutic role?
    Martoni A; Guaraldi M; Piana E
    Ann Oncol; 1999; 10 Suppl 5():S19-23. PubMed ID: 10582134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits.
    Kohno E; Murase S; Nishikata M; Okamura N; Matzno S; Kuwahara T; Matsuyama K
    Int J Med Sci; 2008 Jul; 5(4):218-23. PubMed ID: 18695742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic consequences of treating patients with peripheral neuropathic pain with brand name or generic drugs in routine clinical practice: The effects of age and sex.
    Navarro-Artieda R; Rejas-Gutiérrez J; Pérez-Paramo M; Sicras-Mainar A
    Neurologia (Engl Ed); 2018 Apr; 33(3):141-153. PubMed ID: 27321171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and economic consequences in patients initiating therapy with clopidogrel brand-name vs. generic: A real-life retrospective study].
    Sicras-Mainar A; Escobar-Cervantes C; Micó-Pérez RM; Llisterri-Caro JL
    Semergen; 2020; 46(1):16-26. PubMed ID: 31345684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.
    Chiu WH; Su WC; Li CL; Chen CL; Lin CF
    Oncotarget; 2015 Aug; 6(24):20513-24. PubMed ID: 26001295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.